HarmonyCa vs Sculptra vs Radiesse: what's the real difference?

Sculptra is poly-L-lactic acid (PLLA), a molecule with no filling gel that works only through gradual collagen stimulation. Radiesse is calcium hydroxylapatite (CaHA) in a carboxymethylcellulose gel, giving modest initial volume plus the same collagen-building mechanism. HarmonyCa combines that same CaHA mineral with cross-linked hyaluronic acid in one syringe, adding an immediate, HA-driven lift on top of the progressive collagen response. The choice depends on whether the priority is diffuse long-term restoration, structural volume, or a same-day visible change.

Radiesse vs Sculptra vs HarmonyCa — which one lasts longest?

A systematic review pooling fourteen studies of PLLA- and CaHA-based biostimulators reported that PLLA (Sculptra) effects were maintained for up to twenty-five months, against twelve to eighteen months for CaHA-based results (Radiesse) — the longer of the two molecule classes that review covered. The hybrid was not in that review, and no source cited here puts it on the same scale: the prospective post-marketing study of HarmonyCa followed patients to Month 12 and found responder rates still high at that visit, which is where the follow-up ended rather than where the effect was measured to stop. These are ranges observed across the patients each study followed, not guarantees for an individual case.

What is the best biostimulator for the face?

There is no single best biostimulator for every face — the right one depends on the indication. Diffuse volume loss across several regions, with no urgency for immediate change, tends to favor a single-mechanism product like Sculptra. Structural volume concentrated in the mid-face tends to favor standard-concentration Radiesse. A same-day visible correction alongside ongoing collagen stimulation tends to favor the HarmonyCa hybrid. A clinical evaluation determines which applies to a specific face.

What is the best biostimulator overall, not just for the face?

Biostimulators are chosen by the tissue problem being solved, not ranked in the abstract. Hyperdiluted calcium hydroxylapatite is the formulation built for skin quality and laxity over larger, thin-skinned areas such as the neck, décolletage, arms or hands, while the same CaHA at standard concentration or combined with hyaluronic acid addresses facial volume instead. ”Best” only has an answer once the target area and goal are specified.

Which of the three gives immediate results?

HarmonyCa is the only one of the three built to produce a visible change on the day of treatment, driven by its cross-linked hyaluronic acid component; a prospective post-marketing study reported high investigator-rated improvement scores as early as Month 1. Radiesse's carrier gel provides some modest initial volume before its fuller, collagen-driven result develops over following weeks. Sculptra has no immediate volumizing component at all — its entire effect builds gradually as collagen deposition progresses.

Can Sculptra, Radiesse and HarmonyCa be combined in the same treatment plan?

In principle, yes — global expert recommendations for the HarmonyCa hybrid specifically discuss combination treatment protocols, and a retrospective series on the same hybrid reported it was compatible with other aesthetic procedures. In practice this means different biostimulators can be sequenced across different areas or stages of a facial plan. Whether combining them fits a specific patient is a clinical decision made during consultation, not something to decide from general comparison information.

Which biostimulator is best for skin quality rather than volume?

Hyperdiluted calcium hydroxylapatite (the CaHA in Radiesse, diluted well beyond its standard concentration) is the formulation documented for skin quality and laxity over larger, thin-skinned areas — the guidance names the face, neck, décolletage, arms, hands, abdomen, buttocks and upper legs. Practical clinical guidance from expert injectors contrasts it with undiluted CaHA used to provide volume: the hyperdilute preparation is distributed across a much larger surface area in a more superficial plane, to stimulate neocollagenesis and elastin formation over time. That guidance addresses CaHA only; no source cited on this page documents a comparable hyperdilute protocol for Sculptra or for the hybrid.

How does a physician decide between HarmonyCa, Sculptra and Radiesse?

The decision follows the clinical finding, not brand familiarity: diffuse volume loss with no urgency for immediate change points toward Sculptra's single mechanism; concentrated mid-face volume points toward standard Radiesse; a same-day visible correction combined with ongoing collagen stimulation points toward the HarmonyCa hybrid; and thin, lax skin over a larger area points toward hyperdiluted Radiesse. A clinical evaluation of anatomy, skin quality and the patient's timeline determines which formulation, or combination, applies.

Face · Product comparison · International

HarmonyCa vs Sculptra vs Radiesse: the three-way comparison, by indication

Three different molecules get compared as if they were competing for the same job. Each is built to answer a different clinical question — this page is organized by indication, not by brand.

Agendar Consulta

The wrong question and the right one

There is no single best biostimulator among HarmonyCa, Sculptra and Radiesse — the right one depends on which clinical problem is being solved: an immediate, visible lift; diffuse collagen restoration spread across many months; or skin quality improvement in a thin-skinned area. Comparing three products by asking which is "best" treats them as competitors chasing the same prize, when in practice they are three different tools built around three different molecules, each suited to a different finding on physical examination.

Sculptra is built on poly-L-lactic acid (PLLA), a synthetic polymer with no filling component of its own. Radiesse is built on calcium hydroxylapatite (CaHA), suspended in a gel carrier. HarmonyCa is a hybrid: the same CaHA microspheres, but suspended in cross-linked hyaluronic acid instead of a plain carrier gel. Because two of the three share the CaHA mineral and all three eventually produce a collagen response, they are easily read as versions of the same idea. They are not: the presence or absence of a hyaluronic acid component decides what happens in the tissue in the first weeks after injection, and that is the variable that should drive the choice.

This page is organized by indication rather than by brand, precisely because the honest answer to "which is best" is "best for what". Each of the following sections names a clinical situation, the formulation documented for it and the criterion behind that judgment, with the published source for each claim. A declaration of no commercial relationship with any of the three manufacturers closes the page.

Three molecules side by side

Placing the three molecules next to each other clarifies why they are not competing for the same job.

Sculptra's active ingredient, poly-L-lactic acid, is a synthetic, biocompatible, biodegradable polymer with no volumizing gel of its own. A physiochemical review of PLLA describes how the size and chemical attributes of its microparticles provoke a subclinical inflammatory response that stimulates collagen deposition in the extracellular matrix, restoring facial volume in what the review calls a controlled, predictable and long-lasting manner. Because the mechanism depends entirely on that gradual biological response, PLLA vials are supplied as a lyophilized powder reconstituted with sterile water immediately before injection — there is no pre-filled gel doing any of the initial work.

Radiesse's active ingredient, the same calcium hydroxylapatite mineral used in the hybrid described below, is suspended in a carboxymethylcellulose gel rather than reconstituted in water. That carrier gel provides some initial volume before it reabsorbs over the following weeks, after which the CaHA microspheres continue stimulating collagen on their own, longer timeline. A systematic review of facial collagen biostimulators built on PLLA and CaHA, pooling findings across fourteen eligible studies, reported that PLLA's effects were maintained for up to twenty-five months, while CaHA-based results lasted twelve to eighteen months; the same review noted that adverse effects were generally mild — most often pain and swelling at the injection site — with one serious case of compression necrosis reported with CaHA.

Molecule	Carrier	Immediate volume	Time to visible effect	Number of sessions	Duration	Best-suited indication
Poly-L-lactic acid (PLLA) — Sculptra	Lyophilized microparticles reconstituted with sterile water before injection	None — the molecule has no filling gel of its own	Gradual, over the weeks following treatment as collagen deposition progresses	Not specified in the sources cited here	Up to 25 months	Diffuse facial volume loss across multiple regions, when a single predictable long-term mechanism is preferred over an immediate change
Calcium hydroxylapatite (CaHA) — Radiesse	Carboxymethylcellulose gel	Modest, from the carrier gel before it reabsorbs	Partly immediate from the carrier; the fuller collagen-driven effect develops over the following weeks	Not specified in the sources cited here; the hyperdilute guidance describes a technique spread over a larger surface rather than a number of visits	12 to 18 months	Structural volume in the mid-face at standard concentration; skin quality and laxity over larger areas such as the neck, décolletage or hands when hyperdiluted
CaHA microspheres in cross-linked hyaluronic acid — HarmonyCa	Cross-linked hyaluronic acid gel with lidocaine	Yes, immediate — driven by the hyaluronic acid component	Immediate, from the day of treatment	One treatment, with an optional touch-up two weeks later, in the prospective study	The prospective study followed patients to Month 12 — its final visit — with responder rates still high there, and concluded effects lasting up to one year	Same-day visible correction combined with progressive collagen stimulation in the mid-face

No source cited on this page enrolls all three products in the same trial. One of them does compare two of the molecule classes directly: the systematic review above sets PLLA against CaHA, and it is where the Duration column takes both of those figures from. The hybrid is absent from that comparison — its own literature, covered in the next section, stands on its own. Reading the table as "what each product is documented to do", rather than "which product wins", is the accurate way to use it.

Best option for immediate lift with progressive support

When the clinical need is a visible change on the day of treatment plus an ongoing collagen response afterward, HarmonyCa is the formulation built around that combination.

A prospective, open-label, post-marketing study evaluated the hybrid injectable in patients rated moderate to severe on the Allergan Midface Volume Deficit Scale, treating 110 patients with the standard formulation and 30 with the lidocaine-containing version in the cheek and, optionally, the jawline. At Month 1, 82.8% of patients met the responder threshold on that scale, and the rate remained high through Month 12; Global Aesthetic Improvement Scale responder rates at the same visit were 98.5% investigator-rated and 91.8% participant-rated. Satisfaction was a separate instrument: FACE-Q scores rose 33.3 points for the cheeks and 23.8 points for facial appearance at Month 1. Most treatment-related reactions were mild or moderate injection-site responses, and the study concluded the hybrid was effective and well tolerated for midface augmentation, with effects lasting up to a year. A separate, smaller prospective study used three-dimensional facial scanning on eight female patients with a mean age of forty-seven and found a statistically significant increase in tissue displacement in the mid-face, present immediately after treatment and still measurable at ninety days, describing an immediate lifting effect combined with progressive tissue displacement that reduced visible sagging.

An Italian retrospective review of 129 patients treated with the hybrid filler reported improvement in facial appearance — particularly during movement — with only minor, self-resolving adverse events, and noted the product's compatibility with other cosmetic procedures and medications; because the design was retrospective, it reads as a real-world observation rather than as controlled evidence. A global panel of eight international expert injectors, convened to write practice recommendations for the hybrid, advised using a cannula rather than a needle, injecting in small volumes along the ligament lines and zygomatic arch, and retreating only if mild-to-moderate laxity recurs.

Sculptra vs. Radiesse: Understanding the Biology Behind Bio-stimulators

Best option for diffuse deflation over time

When volume loss is spread across multiple regions of the face rather than concentrated in one area, and there is no urgency for a same-day change, Sculptra's single, predictable mechanism is the formulation built for that pattern.

Because PLLA has no filling gel, its entire effect comes from the gradual, controlled collagen deposition described in the physiochemical review cited above — there is no separate carrier component with its own reabsorption curve to account for, which is precisely what makes the trajectory more predictable to plan and to explain to a patient treating several regions at once. The systematic review that pooled fourteen studies of PLLA- and CaHA-based biostimulators found that PLLA's effects were maintained for up to twenty-five months, the longest duration reported among the biostimulators covered in that review, alongside significant improvements in skin elasticity, wrinkle reduction and facial volume across both molecule classes.

What routes a patient into this section is therefore the shape of the problem, not a preference for a brand: volume loss read across several regions at once, and a willingness to wait for the result. Remove either condition — the loss is concentrated in one area, or the change has to be visible on the day of treatment — and the reader belongs in one of the other two sections.

Best option for skin quality and thin-skin areas

When the finding on examination is loose, thin skin rather than lost volume — commonly on the neck, décolletage, upper arms or the back of the hands — hyperdiluted Radiesse is the formulation built specifically for that job, and it is a different clinical tool from standard-concentration Radiesse used for cheek volume.

Practical guidance for clinicians, developed from three regional continuing-education meetings where twelve expert physician injectors answered the questions most frequently raised by their audiences, lays out dilution ratios, injection depth and technique specifically for hyperdilute CaHA. That guidance describes how, unlike undiluted CaHA used to provide volume, the hyperdilute preparation is spread across a much larger surface area in a more superficial plane, where it stimulates neocollagenesis and elastin formation rather than adding bulk — a tissue response the guidance attributes to the absence of lymphocytic infiltrates and a predominance of type 1 collagen in how CaHA is handled by the body. Areas named in that guidance include the face, arms, hands, neck, décolletage, upper arms, abdomen, buttocks and upper legs, along with cellulite and striae.

Because this is expert practical guidance built from clinician experience rather than a controlled trial, it should be read as consensus-level how-to rather than as trial evidence — the same caveat that applies to the global recommendations for the hybrid described earlier. The hyperdilute guidance covers CaHA and nothing else: it does not discuss PLLA or the hybrid, and no other source cited on this page documents a hyperdilute protocol for either of them — so what is documented here for thin, lax skin over a large surface is a CaHA technique, and the silence about the other two is not itself a finding about them.

How the plan is sequenced when more than one is indicated

Facial aging rarely presents as a single isolated finding: volume loss, ligament laxity and skin-quality change often coexist in the same face, which is why a plan may route to more than one of the three rather than to a single product for the whole face.

The global expert recommendations for the hybrid explicitly discuss combination treatment protocols as part of routine practice, and the Italian retrospective series on the same hybrid reported that it proved compatible with other aesthetic procedures and medications in the patients it followed. In practice, that can mean using the hybrid where an immediate, visible change matters most — typically the mid-face — while addressing more diffuse volume loss elsewhere with a single-mechanism biostimulator, or treating thin, lax skin on the neck or décolletage with the hyperdilute technique described above, on a separate visit.

Combined histories are already the norm rather than the exception: in the Italian series, 86 of the 129 patients — two-thirds — had undergone another cosmetic procedure in the six months before their hybrid treatment, whether laser, botulinum toxin, another filler or surgery. That describes who was treated; it is not a rule about intervals, and none of the sources cited here tested how long to leave between one procedure and the next. Sequencing decisions of that kind — which product, in which area, in which order, and how anything already scheduled changes the sequence — are made during a clinical evaluation, not from a page comparing products in the abstract.

What no comparison can tell you without an exam

Every distinction described on this page — immediate versus gradual, diffuse versus targeted, deep volume versus superficial skin quality — depends on physical findings that a comparison page cannot see: the depth and distribution of the volume loss, the quality and thickness of the skin, the degree of ligament laxity, and how much change the patient wants on the day of treatment versus over the following months.

No source cited above tested HarmonyCa, Sculptra and Radiesse against each other in the same patients. The systematic review does compare two of the molecule classes, PLLA against CaHA, but the hybrid is absent from it, and nothing cited here places the hybrid on a scale with either of the other two. That is a real limitation of the evidence assembled on this page: the sections above describe what each product is documented to do, and among these sources there is no three-way ranking to report. Turning that documented behavior into a plan for a specific face is precisely the part that requires a clinical evaluation.

A consultation with a licensed physician — one whose active registration can be verified directly at cfm.org.br — is the appropriate next step to determine which of these formulations, or which sequence of them, fits an individual case. No result from any of the studies described on this page is a guarantee for any individual patient; each reports a range observed across the group it studied, confirmed at follow-up visits rather than promised in advance.

No commercial relationship with any manufacturer

The three products come from three manufacturers: Sculptra from Galderma, Radiesse from Merz Aesthetics, HarmonyCa from Allergan Aesthetics, an AbbVie company. Dr. Thiago Perfeito's practice has no commercial relationship, sponsorship or financial arrangement with any of the three manufacturers, and none of the three products is presented here as superior in general terms. Industry ties run through the sources on more than one side, and are named here rather than left to inference. Two of the sources on the hybrid declare them: the prospective post-marketing study, whose author list includes employees of Allergan Aesthetics, and the global expert recommendations, whose panel members declare paid roles with the same company. The practical guidance behind the skin-quality section above carries the equivalent tie for the other product — it disclosed funding from Merz North America, part of the Merz group that manufactures Radiesse, and nearly all of its twelve author-injectors declare paid relationships with that company. The three-dimensional prospective study of the hybrid, by Queiroz and colleagues, declares no conflicts of interest. Industry involvement does not make a finding wrong; it is stated so each source can be weighed knowing who paid for it.

All three are legitimate, widely used tools in facial biostimulation, each with a defined place in a treatment plan built around indication rather than brand familiarity. The right choice for an individual patient — one product, or a sequence of more than one — is made during a clinical evaluation of anatomy, skin quality, degree of volume loss and treatment timeline, not by which name is more heavily marketed.

Frequently asked questions about HarmonyCa vs Sculptra vs Radiesse

HarmonyCa vs Sculptra vs Radiesse: what's the real difference?
Sculptra is poly-L-lactic acid (PLLA), a molecule with no filling gel that works only through gradual collagen stimulation. Radiesse is calcium hydroxylapatite (CaHA) in a carboxymethylcellulose gel, giving modest initial volume plus the same collagen-building mechanism. HarmonyCa combines that same CaHA mineral with cross-linked hyaluronic acid in one syringe, adding an immediate, HA-driven lift on top of the progressive collagen response. The choice depends on whether the priority is diffuse long-term restoration, structural volume, or a same-day visible change.
Radiesse vs Sculptra vs HarmonyCa — which one lasts longest?
A systematic review pooling fourteen studies of PLLA- and CaHA-based biostimulators reported that PLLA (Sculptra) effects were maintained for up to twenty-five months, against twelve to eighteen months for CaHA-based results (Radiesse) — the longer of the two molecule classes that review covered. The hybrid was not in that review, and no source cited here puts it on the same scale: the prospective post-marketing study of HarmonyCa followed patients to Month 12 and found responder rates still high at that visit, which is where the follow-up ended rather than where the effect was measured to stop. These are ranges observed across the patients each study followed, not guarantees for an individual case.
What is the best biostimulator for the face?
There is no single best biostimulator for every face — the right one depends on the indication. Diffuse volume loss across several regions, with no urgency for immediate change, tends to favor a single-mechanism product like Sculptra. Structural volume concentrated in the mid-face tends to favor standard-concentration Radiesse. A same-day visible correction alongside ongoing collagen stimulation tends to favor the HarmonyCa hybrid. A clinical evaluation determines which applies to a specific face.
What is the best biostimulator overall, not just for the face?
Biostimulators are chosen by the tissue problem being solved, not ranked in the abstract. Hyperdiluted calcium hydroxylapatite is the formulation built for skin quality and laxity over larger, thin-skinned areas such as the neck, décolletage, arms or hands, while the same CaHA at standard concentration or combined with hyaluronic acid addresses facial volume instead. "Best" only has an answer once the target area and goal are specified.
Which of the three gives immediate results?
HarmonyCa is the only one of the three built to produce a visible change on the day of treatment, driven by its cross-linked hyaluronic acid component; a prospective post-marketing study reported high investigator-rated improvement scores as early as Month 1. Radiesse's carrier gel provides some modest initial volume before its fuller, collagen-driven result develops over following weeks. Sculptra has no immediate volumizing component at all — its entire effect builds gradually as collagen deposition progresses.
Can Sculptra, Radiesse and HarmonyCa be combined in the same treatment plan?
In principle, yes — global expert recommendations for the HarmonyCa hybrid specifically discuss combination treatment protocols, and a retrospective series on the same hybrid reported it was compatible with other aesthetic procedures. In practice this means different biostimulators can be sequenced across different areas or stages of a facial plan. Whether combining them fits a specific patient is a clinical decision made during consultation, not something to decide from general comparison information.
Which biostimulator is best for skin quality rather than volume?
Hyperdiluted calcium hydroxylapatite (the CaHA in Radiesse, diluted well beyond its standard concentration) is the formulation documented for skin quality and laxity over larger, thin-skinned areas — the guidance names the face, neck, décolletage, arms, hands, abdomen, buttocks and upper legs. Practical clinical guidance from expert injectors contrasts it with undiluted CaHA used to provide volume: the hyperdilute preparation is distributed across a much larger surface area in a more superficial plane, to stimulate neocollagenesis and elastin formation over time. That guidance addresses CaHA only; no source cited on this page documents a comparable hyperdilute protocol for Sculptra or for the hybrid.
How does a physician decide between HarmonyCa, Sculptra and Radiesse?
The decision follows the clinical finding, not brand familiarity: diffuse volume loss with no urgency for immediate change points toward Sculptra's single mechanism; concentrated mid-face volume points toward standard Radiesse; a same-day visible correction combined with ongoing collagen stimulation points toward the HarmonyCa hybrid; and thin, lax skin over a larger area points toward hyperdiluted Radiesse. A clinical evaluation of anatomy, skin quality and the patient's timeline determines which formulation, or combination, applies.

References

Cavallini M, Braz A, Greiner-Krüger D et al. Global Recommendations for Facial Rejuvenation Using a Hyaluronic Acid and Calcium Hydroxyapatite Hybrid Injectable. J Cosmet Dermatol. 2026;25(1):e70608. PMID: 41566538 · doi:10.1111/jocd.70608
Gritti A, Salomon M, Elmaleh L et al. A Prospective, Open-Label, Post Marketing Study of the Safety and Effectiveness of a Hyaluronic Acid and Calcium Hydroxyapatite Hybrid Injectable. J Cosmet Dermatol. 2025;24(9):e70430. PMID: 40948024 · doi:10.1111/jocd.70430
Proietti I, Spagnoli A, Favaroni A et al. HArmonyCa™ hybrid filler to restore connective tissue: An Italian real-life retrospective study. J Cosmet Dermatol. 2024;23(12):3883-3892. PMID: 39360597 · doi:10.1111/jocd.16503
Queiroz TP, Lucatelli SR, Jellmayer JA et al. Analysis in 3D of Hybrid Injectable Combining Hyaluronic Acid and Calcium Hydroxyapatite: Prospective Study. Aesthetic Plast Surg. 2026;50(7):2714-2722. PMID: 41345305 · doi:10.1007/s00266-025-05467-7
Ferreira ACM, Silva LR, Espasandin I et al. Efficacy, Durability, and Safety of Collagen Biostimulators Based on Poly-L-Lactic Acid (PLLA) and Calcium Hydroxyapatite (CaHA) in the Face: A Systematic Review. Aesthetic Plast Surg. 2026;50(3):1291-1300. PMID: 41184662 · doi:10.1007/s00266-025-05412-8
Fitzgerald R, Bass LM, Goldberg DJ et al. Physiochemical Characteristics of Poly-L-Lactic Acid (PLLA). Aesthet Surg J. 2018;38(suppl_1):S13-S17. PMID: 29897517 · doi:10.1093/asj/sjy012
Lorenc ZP, Black JM, Cheung JS et al. Skin Tightening With Hyperdilute CaHA: Dilution Practices and Practical Guidance for Clinical Practice. Aesthet Surg J. 2022;42(1):NP29-NP37. PMID: 34192299 · doi:10.1093/asj/sjab269

Reviewed by Dr. Thiago Perfeito — Aesthetic and Regenerative Medicine, CRM-DF 23199. Updated on 2 de setembro de 2026.

Best collagen biostimulator · HarmonyCa vs Radiesse · HarmonyCa vs Sculptra

Not sure which biostimulator fits your face?

HarmonyCa, Sculptra and Radiesse each answer a different clinical question. Dr. Thiago Perfeito can evaluate your anatomy and timeline during a consultation in Brasília and recommend the formulation, or sequence of formulations, that fits your case.

Book via WhatsApp About the doctor